KELP TABLETS 150MCG 150 MCG
IODINE : 150 MCG · DIN 00534617 · HALL LABORATORIES, LTD.
Health Canada status: CANCELLED POST MARKET
What is KELP TABLETS 150MCG?
KELP TABLETS 150MCG 150 MCG contains IODINE : 150 MCG. It is listed in the Health Canada Drug Product Database under DIN 00534617, held by HALL LABORATORIES, LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 11-Sep-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00534617 |
|---|---|
| Brand name | KELP TABLETS 150MCG |
| Generic / active ingredient | IODINE : 150 MCG |
| Manufacturer | HALL LABORATORIES, LTD. |
| Strength | 150 MCG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | H03CA IODINE THERAPY |
| AHFS class | 88:20.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 11-Sep-2003 |
| Original market date | 1981-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code H03CA IODINE THERAPY. 0 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| IODAMINOL TAB 10MG | 10 MG | TABLET | DESBERGERS LTÉE, DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | DIN 00086339 |
| IODAMINOL TAB 30MG | 30 MG | TABLET | DESBERGERS LTÉE, DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | DIN 00242799 |
| IODIN RATION TAB 0.15MG | .15 MG | TABLET | NION CORP | CANCELLED POST MARKET | DIN 00399183 |
| IODINE CTR SRT 300MG | 300 MCG | TABLET (EXTENDED-RELEASE) | BIOENERGY INC. | CANCELLED POST MARKET | DIN 00540129 |
| IODINE TAB 3MG | 3 MG | TABLET | THERAPEUTIC FOODS CO. | CANCELLED POST MARKET | DIN 00190829 |
| LIQUID IODINE | .15 MG / .04 ML | LIQUID | SEROYAL INTERNATIONAL INC. | CANCELLED POST MARKET | DIN 00554642 |
| SODIUM IODIDE INJ 100MG/ML | Strength | Liquid | SABEX INC 110 De Lauzon Street Boucherville Quebec Canada J4B 1E6 | CANCELLED POST MARKET | DIN 00807680 |
| THYROBLOCK TAB 130MG | 130 MG | TABLET | CARTER-HORNER CORP. | CANCELLED POST MARKET | DIN 00518077 |
Who else supplies IODINE THERAPY worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. IODINE THERAPY appears in 32 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.